InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the detailed record of transactions filed by Feldmeier, Dr. Hans-Georg, Management Board. Insider active across 1 company, notably Dermapharm Holding SE. Aggregated, 2 filings have been published. History available since 2 June 2025. The latest transaction was filed on 2 June 2025 (Buy). Regulator: BaFin. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条